Risk of Endometrial Cancer After Tamoxifen Treatment of Breast Cancer

The Lancet - United Kingdom
doi 10.1016/s0140-6736(94)92692-1
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

Novel Breast Cancer Risk Alleles and Endometrial Cancer Risk

International Journal of Cancer
Cancer ResearchOncology
2008English

Tamoxifen Treatment for Male Breast Cancer and Risk of Thromboembolism: Prospective Cohort Analysis

British Journal of Cancer
Cancer ResearchOncology
2019English

Risk Factors for Developing Endometrial Cancer After Benign Endometrial Sampling

Obstetrics and Gynecology
GynecologyObstetrics
2012English

Lymphedema After Treatment for Endometrial Cancer − a Review of Prevalence and Risk Factors

European Journal of Obstetrics, Gynecology and Reproductive Biology
GynecologyReproductive MedicineObstetrics
2017English

Surgical Treatment of Endometrial Cancer

Journal of Cancer Therapy
2010English

Short Commentary on Lymphedema After Treatment for Endometrial Cancer

Gynecology & Obstetrics
2017English

Risk of Cancer After Growth-Hormone Treatment

The Lancet
Medicine
2002English

Heart Failure After Treatment for Breast Cancer

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2020English

Exercise After Breast Cancer Treatment: Current Perspectives

Breast Cancer: Targets and Therapy
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy